Surmodics | SRDX - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.36B 178M 2025-12
Align Technology USD 176.6M 81.86M 2025-12
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Artivion USD 11.4M 7.84M 2025-12
Baxter International USD 121M 12M 2025-09
Boston Scientific USD 938M 3M 2025-09
EDAP TMS EUR -4.91M 597K 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
J&J USD 4.97B 2.53B 2025-12
Merit Medical Systems USD 73.18M 29.8M 2025-09
Mesa Laboratories USD -2.22M 6.03M 2024-12
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Option Care Health USD 68.97M 109K 2025-09
Stryker USD 1.03B 13M 2025-09
Surmodics USD -7.51M 1.69M 2024-09
Trinity Biotech USD -5.06M 10.74M 2025-09